258 related articles for article (PubMed ID: 29604936)
1. Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis.
Cho AA; Bonavida B
Crit Rev Oncog; 2017; 22(1-2):49-61. PubMed ID: 29604936
[TBL] [Abstract][Full Text] [Related]
2. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.
Bonavida B; Baritaki S
Crit Rev Oncog; 2011; 16(3-4):211-26. PubMed ID: 22248055
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic YY1 Inhibitors in Cancer: ALL in ONE.
Bonavida B
Crit Rev Oncog; 2017; 22(1-2):37-47. PubMed ID: 29604935
[TBL] [Abstract][Full Text] [Related]
4. The Forgotten YY2 in Reported YY1 Expression Levels in Human Cancers.
Kaufhold S; Aziz N; Bonavida B
Crit Rev Oncog; 2017; 22(1-2):63-73. PubMed ID: 29604937
[TBL] [Abstract][Full Text] [Related]
5. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.
Bonavida B; Baritaki S
Nitric Oxide; 2011 Jan; 24(1):1-7. PubMed ID: 20933602
[TBL] [Abstract][Full Text] [Related]
6. YY1 Is an Inducer of Cancer Metastasis.
Wang W; Li D; Sui G
Crit Rev Oncog; 2017; 22(1-2):1-11. PubMed ID: 29604932
[TBL] [Abstract][Full Text] [Related]
7. Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer.
Huerta-Yepez S; Baritaki S; Baay-Guzman G; Hernandez-Luna MA; Hernandez-Cueto A; Vega MI; Bonavida B
Nitric Oxide; 2013 Feb; 29():17-24. PubMed ID: 23246440
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: a therapeutic target.
Bonavida B; Kaufhold S
Pharmacol Ther; 2015 Jun; 150():149-68. PubMed ID: 25619146
[TBL] [Abstract][Full Text] [Related]
9. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
[TBL] [Abstract][Full Text] [Related]
10. The Yin and Yang of YY1 in tumor growth and suppression.
Khachigian LM
Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
[TBL] [Abstract][Full Text] [Related]
11. Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells.
Gao D; Wang L; Zhang H; Yan X; Yang J; Zhou R; Chang X; Sun Y; Tian S; Yao Z; Zhang K; Liu Z; Ma Z
FEBS J; 2018 Nov; 285(22):4229-4245. PubMed ID: 30251328
[TBL] [Abstract][Full Text] [Related]
12. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Kaufhold S; Garbán H; Bonavida B
J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
[TBL] [Abstract][Full Text] [Related]
13. The role of YY1 in oncogenesis and its potential as a drug target in cancer therapies.
Shi J; Hao A; Zhang Q; Sui G
Curr Cancer Drug Targets; 2015; 15(2):145-57. PubMed ID: 25817371
[TBL] [Abstract][Full Text] [Related]
14. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer.
Wottrich S; Kaufhold S; Chrysos E; Zoras O; Baritaki S; Bonavida B
Drug Resist Updat; 2017 Jan; 30():28-38. PubMed ID: 28363333
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Epithelial-to-Mesenchymal Transition (EMT) in Cancer by Nitric Oxide: Pivotal Roles of Nitrosylation of NF-κB, YY1 and Snail.
Bonavida B; Baritaki S
For Immunopathol Dis Therap; 2012; 3(2):125-133. PubMed ID: 24729932
[TBL] [Abstract][Full Text] [Related]
16. YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis.
Yang T; Shu F; Yang H; Heng C; Zhou Y; Chen Y; Qian X; Du L; Zhu X; Lu Q; Yin X
Metabolism; 2019 Jul; 96():33-45. PubMed ID: 31028762
[TBL] [Abstract][Full Text] [Related]
17. Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer.
Liu J; Chen X; Ward T; Mao Y; Bockhorn J; Liu X; Wang G; Pegram M; Shen K
Int J Biochem Cell Biol; 2016 Feb; 71():12-23. PubMed ID: 26643609
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
19. The Multilayered Regulation of the Oncogenic Protein YY1.
Rizkallah R; Hurt MM
Crit Rev Oncog; 2017; 22(1-2):109-129. PubMed ID: 29604940
[TBL] [Abstract][Full Text] [Related]
20. RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop.
Bonavida B
Crit Rev Oncog; 2014; 19(6):431-45. PubMed ID: 25597353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
